October 2026
1. BLACK CJ, Chuah KH, Nasser Y, Remes-Troche JM, et al
   Irritable bowel syndrome and related disorders of gut-brain interaction.
   Lancet. 2026 Oct 29:S0140-6736(26)01500-X. doi: 10.1016/S0140-6736(26)01500.
   

   >> Share

   
   September 2026
2. JOHNSEN PH, Juul FE, Hoff DAL, Hillestad ER, et al
   Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial.
   Lancet. 2026 Sep 24:S0140-6736(26)01424-8. doi: 10.1016/S0140-6736(26)01424.
   

   >> Share

   
   
3. LIU J, Shin A
   Healthy donor faecal microbiota transplantation in irritable bowel syndrome: interpreting negative findings.
   Lancet. 2026 Sep 24:S0140-6736(26)01815-5. doi: 10.1016/S0140-6736(26)01815.
   

   >> Share

   
   October 2023
4. FORD AC, Wright-Hughes A, Alderson SL, Ow PL, et al
   Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.
   Lancet. 2023 Oct 16:S0140-6736(23)01523-4. doi: 10.1016/S0140-6736(23)01523.
   

   >> Share

   
   
5. DE WIT N, Keszthelyi D
   Low-dose amitriptyline in irritable bowel syndrome: ready for primary care?
   Lancet. 2023 Oct 16:S0140-6736(23)01725-7. doi: 10.1016/S0140-6736(23)01725.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share